share_log

新銳醫藥:執行董事辭任

NEW RAY MEDIC: RESIGNATION OF EXECUTIVE DIRECTOR

HKEX ·  Oct 16, 2024 20:33

Summary by Futu AI

新銳醫藥國際控股有限公司(「本公司」)於2024年10月16日宣布,執行董事霍志宏先生因其他業務追求及承擔,已辭任執行董事及董事會企業管治委員會成員之職務。霍先生的辭任將促使企業管治委員會進行重組,新的組成將由王秋勤女士擔任主席,施禮賢先生及周灣女士為成員。霍先生確認與董事會無意見分歧,且無需向股東或香港聯合交易所有限公司報告的相關事項。董事會對霍先生在任期間對公司的貢獻表示感謝。
新銳醫藥國際控股有限公司(「本公司」)於2024年10月16日宣布,執行董事霍志宏先生因其他業務追求及承擔,已辭任執行董事及董事會企業管治委員會成員之職務。霍先生的辭任將促使企業管治委員會進行重組,新的組成將由王秋勤女士擔任主席,施禮賢先生及周灣女士為成員。霍先生確認與董事會無意見分歧,且無需向股東或香港聯合交易所有限公司報告的相關事項。董事會對霍先生在任期間對公司的貢獻表示感謝。
New Ray Medic International Holdings Limited ("the Company") announced on October 16, 2024, that Mr. Ho Chi Hung, an executive director, has resigned from his position as executive director and member of the board of directors' corporate governance committee due to pursuing other business interests and commitments. Mr. Ho's resignation will lead to a restructuring of the corporate governance committee, with the new composition chaired by Ms. Wang Qiuchin, and Mr. She Li-xian and Ms. Zhou Wan as members. Mr. Ho has confirmed no disagreements with the board of directors and no matters requiring reporting to shareholders or the Hong Kong Stock Exchange. The board of directors expresses gratitude to Mr. Ho for his contributions during his tenure.
New Ray Medic International Holdings Limited ("the Company") announced on October 16, 2024, that Mr. Ho Chi Hung, an executive director, has resigned from his position as executive director and member of the board of directors' corporate governance committee due to pursuing other business interests and commitments. Mr. Ho's resignation will lead to a restructuring of the corporate governance committee, with the new composition chaired by Ms. Wang Qiuchin, and Mr. She Li-xian and Ms. Zhou Wan as members. Mr. Ho has confirmed no disagreements with the board of directors and no matters requiring reporting to shareholders or the Hong Kong Stock Exchange. The board of directors expresses gratitude to Mr. Ho for his contributions during his tenure.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.